Adsilico
2 known investors
adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing. It serves medical device developers seeking to accelerate R&D and reduce clinical trial risk.
AI & Machine LearningHealthtechMedical Devices
Founders & leadership
Investors · 2
Companies House · registry record
View on Companies House ↗- Registered name
- ADSILICO LIMITED
- Company number
- 14263453
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 29 Jul 2022
- Registered office
- Nexus, Discovery Way, Leeds, West Yorkshire, LS2 3AA
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 28 Jul 2026 · next due 11 Aug 2027
Current officers · 4
- Cassandra Clare Doherty — director, appointed 20 Nov 2025
- Sheena Louise Macpherson — director, appointed 22 Feb 2024
- Christopher Lee Richardson — director, appointed 28 Aug 2024
- Parkwalk Advisors Ltd — corporate director, appointed 23 Feb 2024
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Adsilico do?
- adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing. It serves medical device developers seeking to accelerate R&D and reduce clinical trial risk.
- Who founded Adsilico?
- Adsilico was founded by Dr Nishant Ravikumar, Dr Zeike Taylor, Prof Alejandro Frangi.
- Who are Adsilico's investors?
- Adsilico's investors include Northern Gritstone, Parkwalk Advisors.